Evidence map›Paper›PMID 37510157›Full record

ReviewDiagnostics (Basel, Switzerland)2023

Pearls and Pitfalls of Adaptive Optics Ophthalmoscopy in Inherited Retinal Diseases.

Helia Ashourizadeh, Maryam Fakhri, Kiana Hassanpour, Ali Masoudi, Sattar Jalali, Danial Roshandel, Fred K Chen

Open access · goldAbstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Helia AshourizadehDepartment of Ophthalmology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0003-1868-4845
Maryam FakhriOphthalmic Research Center, Research Institute for Ophthalmology and Vision Sciences, Shahid Beheshti University of Medical Sciences, Tehran 16666, Iran.
Kiana HassanpourOphthalmic Research Center, Research Institute for Ophthalmology and Vision Sciences, Shahid Beheshti University of Medical Sciences, Tehran 16666, Iran.ORCID 0000-0002-1788-7352
Ali MasoudiStein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Sattar JalaliDepartment of Physics, Central Tehran Branch, Islamic Azad University, Tehran 19558, Iran.
Danial RoshandelCentre for Ophthalmology and Visual Science, The University of Western Australia, Nedlands, WA 6009, Australia.ORCID 0000-0002-6716-6406
Fred K ChenCentre for Ophthalmology and Visual Science, The University of Western Australia, Nedlands, WA 6009, Australia.ORCID 0000-0003-2809-9930
Lions Eye Institute · AUShahid Beheshti University of Medical Sciences · IRIslamic Azad University Central Tehran Branch · IRMayo Clinic · USUniversity of California, Los Angeles · US

Funding

National Health and Medical Research Council GNT1054712National Health and Medical Research Council GNT1116360National Health and Medical Research Council GNT1188694National Health and Medical Research Council MRF1142962
6 · The paper itself

Abstract

Adaptive optics (AO) retinal imaging enables individual photoreceptors to be visualized in the clinical setting. AO imaging can be a powerful clinical tool for detecting photoreceptor degeneration at a cellular level that might be overlooked through conventional structural assessments, such as spectral-domain optical coherence tomography (SD-OCT). Therefore, AO imaging has gained significant interest in the study of photoreceptor degeneration, one of the most common causes of inherited blindness. Growing evidence supports that AO imaging may be useful for diagnosing early-stage retinal dystrophy before it becomes apparent on fundus examination or conventional retinal imaging. In addition, serial AO imaging may detect structural disease progression in early-stage disease over a shorter period compared to SD-OCT. Although AO imaging is gaining popularity as a structural endpoint in clinical trials, the results should be interpreted with caution due to several pitfalls, including the lack of standardized imaging and image analysis protocols, frequent ocular comorbidities that affect image quality, and significant interindividual variation of normal values. Herein, we summarize the current state-of-the-art AO imaging and review its potential applications, limitations, and pitfalls in patients with inherited retinal diseases.

Indexed as

adaptive opticsinherited retinal diseasephotoreceptorretinal dystrophyrod-cone dystrophy

Identifiers

PMID37510157
PMCPMC10377978
OpenAlexW4384817221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.